丹参川芎嗪注射液治疗冠心病心绞痛的临床疗效观察

Clinical curative effect observation of salvia miltiorrhiza ligustrazine injection in treating angina pectoris of coronary heart disease

目的:总结分析丹参川芎嗪注射液治疗冠心病心绞痛的临床治疗体会,为以后的临床诊断治疗提供科学依据。方法:本次研究通过收集本院94例冠心病心绞痛患者,随机分为对照组和治疗组,每组47例。对照组患者实施常规治疗,治疗组患者在常规治疗基础上加用丹参川芎嗪注射液进行治疗,比较两组患者的治疗效果。结果:94例冠心病患者进行治疗后,治疗组患者临床疗效及心电图疗效的总有效率显著高于对照组的总有效率,且差异均具有统计学意义(P>0.05);治疗组患者的Hs-CRP、胆固醇、三酰甘油的水平显著低于对照组患者,且差异均具有统计学意义(P<0.05)。结论:冠心病患者采用川芎嗪进行治疗可以显著提高疗效,值得在以后的临床工作中加以应用。

Objective: To summarize the clinical experience of applying salvia miltiorrhiza ligustrazine injection in the treatment of angina pectoris of coronary heart disease and to provide a scientific basis for the future clinical diagnosis and treatment. Methods: 94 Patients with angina pectoris of coronary heart disease were collected from our hospital and randomly divided into the control group and the treatment group, with 47 cases in each group. The patients in the control group received routine therapy while the patients in the treatment group patients received salvia miltiorrhiza ligustrazine injection treatment on the basis of conventional treatment; the therapeutic effects of two groups were compared. Results: After treatment, the total effective rate, namely, the clinical curative effect and the ECG curative effect of the treatment group was significantly higher than that of the control group, and the differences were statistically significant(P>0.05); Hs-CRP, cholesterol, triglyceride level of patients in the treatment group was significantly lower than that of the control group, and the differences were statistically significant(P<0.05). Conclusion: Applying salvia miltiorrhiza ligustrazine injection could significantly improve curative effect in treating angina pectoris of coronary heart disease, and it was worthy of future clinical application.